The fundraising was led by Belgian investment fund HERAN Partners and the Borski Fund in the Netherlands.

Thirona's flagship product is LungQ, software that has helped the company build a track record as an expert partner for pharmaceutical companies and help advance treatment development in clinical trials, as well as support pulmonary clinical care across the globe, Thirona said.